Clinical trial
Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell…
NCT00004145 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00004145 |
|---|---|
| Title | Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer |
| Official title | Allogeneic Peripheral Blood Stem Cell Transplantation Using a Non-Myeloablative Preparative Regimen for Patients With Hematologic Malignancies |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes |
| Intervention type | Biological, Drug, Procedure |
| Interventions | anti-thymocyte globulin, cyclophosphamide, fludarabine phosphate, peripheral blood stem cell transplantation |
| Enrollment | 16 |
| Start date | Nov 1, 1998 |
| Primary completion | Nov 1, 2003 |
| Completion | Aug 1, 2011 |
| First posted | Feb 16, 2004 |
| Last update posted | Mar 7, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: